NEWLY DIAGNOSED GLIOBLASTOMA
Clinical trials for NEWLY DIAGNOSED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer vaccine enters human trials: could it extend lives?
Disease control Recruiting nowThis study tests a new cancer vaccine for people recently diagnosed with glioblastoma, an aggressive brain tumor. The vaccine aims to train the immune system to attack the cancer. About 35 participants will receive the vaccine after standard surgery and chemoradiation. The goal i…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New gene therapy attacks deadly brain tumors from two sides
Disease control Recruiting nowThis trial tests a new gene therapy called TGX-007 for people with a fast-growing brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two special instructions into the tumor: one helps a common antiviral drug kill cancer cells, and the other wakes up th…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New hope for aggressive brain cancer? drug combo trial launches
Disease control Recruiting nowThis study tests whether adding an experimental drug called silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of newly diagnosed glioblastoma live longer without their cancer growing. The trial is for patients whose tumors have certain genetic…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Sound waves unlock Brain's defenses against deadly tumor
Disease control Recruiting nowThis study tests a new approach for people with a recently diagnosed aggressive brain cancer called glioblastoma. A device with 9 ultrasound emitters is implanted in the skull to temporarily open the blood-brain barrier, allowing immune-boosting drugs to reach the tumor more effe…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Immunotherapy duo takes on deadliest brain cancer
Disease control Recruiting nowThis study tests whether adding two immunotherapy drugs (nivolumab and relatlimab) to standard treatment can help the immune system fight glioblastoma, an aggressive brain cancer. About 92 adults with newly diagnosed glioblastoma will receive these drugs before and after surgery.…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC